XPAR
AMPLI
Market cap348mUSD
Oct 09, Last price
6.25EUR
Name
Amplitude Surgical SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Amplitude Surgical S.A. specializes in the design, development, and commercialization of surgical solutions for orthopedics. Its comprehensive portfolio addresses both primary and revision procedures, targeting a variety of conditions affecting the hip, knee, and lower limbs, with a particular focus on foot and ankle pathologies. This includes a wide array of knee and hip prostheses, as well as specialized implants for the foot and ankle. Beyond implants, Amplitude Surgical offers advanced technological platforms like AMPLIVISION, a computer-aided surgical system; i.M.A.G.E., a customized, single-use instrumentation solution; and E.T.O.I.L.E., an innovative platform facilitating less-invasive anterior surgical approaches. The company also supplies the necessary instrumentation for implant fitting. Operating globally, its products reach approximately 30 countries through an extensive network of distributors and agents, serving patients, surgeons, and healthcare institutions. Established in 1997, Amplitude Surgical S.A. maintains its headquarters in Valence, France.
Related entities
Subsidiaries
SCI LES TILLEULS
Key people
Olivier Jallabert
Chairman of the Board and Chief Executive Officer, Chairman of the Management Board, Founder · since 1997
Muriel Benedetto Marmilloud
Chief Operating Officer
Philippe Garcia
Vice President - Finance, Member of the Management Board
Jean-Christophe Vial
Vice President - International, Member of the Management Board
Bruno Jugnet
Vice President of Marketing, Member of the Management Board
Laurent Geais
Vice President - Research & Development, Member of the Management Board
Mireille Lemery
Member of the Management Board, Director of US Regulatory Affairs
Daniel Caille
Director
Vincent Colomb
Director - Representing APAX Partners Midmarket
Bertrand Pivin
Director
IPO date
Jun 26, 2015
Employees
489
Domiciled in
FR
Incorporated in
FR
Headquarters & legal address
11 COURS JACQUES OFFENBACH
VALENCE 26000
FR
VALENCE 26000
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||